Fractyl Health appoints Dr. Christopher Thompson and Ian Sheffield to board; Amy Schulman resigns

FRACTYL HEALTH, INC.

Christopher Thompson, M.D. appointed as Class I director effective Sept 2, 2025.
Ian Sheffield appointed as Class II director and to audit committee effective Sept 2, 2025.
Each receives $43,500 annual retainer; Sheffield gets additional $10,000 for audit committee; initial option for 45,000 shares vesting over 3 years.
Amy W. Schulman resigned as Class I director and from nominating committee effective Sept 2, 2025; no dispute with company.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.